Trial Profile
A retrospective study assessing the effects of tolvaptan dose on cardiac mortality in patients with acute decompensated heart failure after hospital discharge
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Dec 2018
Price :
$35
*
At a glance
- Drugs Tolvaptan (Primary)
- Indications Heart failure
- Focus Therapeutic Use
- 02 Dec 2018 New trial record